Asensus Surgical Inc. (NYSE:ASXC) has a beta value of 1.56 and has seen 3,831,646 shares traded in the last trading session. The company, currently valued at $488.93 Million, closed the last trade at $2.1 per share which meant it lost -$0.04 on the day or -1.87% during that session. The ASXC stock price is -230.95% off its 52-week high price of $6.95 and 85.71% above the 52-week low of $0.3. If we look at the company’s 10-day average daily trading volume, we find that it stood at 11.29 Million shares traded. The 3-month trading volume is 32.58 Million shares.
The consensus among analysts is that Asensus Surgical Inc. (ASXC) is a Hold stock at the moment, with a recommendation rating of 3. None of the analysts rate the stock as a Sell, while none rate it as Overweight. 2 out of 2 have rated it as a Hold, with no one of them advising it as a Buy. None have rated the stock as Underweight. The expected earnings per share for the stock is -$0.07.
Asensus Surgical Inc. (NYSE:ASXC) trade information
Despite being -1.87% in the red in last session, the stock has traded in the green over the last five days, with the highest price hit on Monday, Apr 26 when the ASXC stock price touched $2.45-1 or saw a rise of 14.29%. Year-to-date, Asensus Surgical Inc. shares have moved 236%, while the 5-day performance has seen it change 11.11%. Over the past 30 days, the shares of Asensus Surgical Inc. (NYSE:ASXC) have changed -38.95%. Short interest in the company has seen 10.95 Million shares shorted with days to cover at 0.34.
Wall Street analysts have a consensus price target for the stock at $1.45, which means that the shares’ value could jump -30.95% from current levels. The projected low price target is $1.45 while the price target rests at a high of $1.45. In that case, then, we find that the current price level is -30.95% off the targeted high while a plunge would see the stock lose -30.95% from current levels.
Asensus Surgical Inc. (ASXC) estimates and forecasts
Figures show that Asensus Surgical Inc. shares have outperformed across the wider relevant industry. The company’s shares have gained +463.15% over the past 6 months, with this year growth rate of 58.73%, compared to 22.2% for the industry. Other than that, the company has, however Increased its growth outlook for the 2021 fiscal year revenue. Growth estimates for the current quarter are 82.9% and 71.4% for the next quarter. Revenue growth from the last financial year stood is estimated to be +138.4%.
2 analysts offering their estimates for the company have set an average revenue estimate of $1.4 Million for the current quarter. 2 have an estimated revenue figure of $1.63 Million for the next quarter concluding in June 01, 2021. Year-ago sales stood $600Million for this quarter, and analysts expect sales will grow by 133.3% for the current quarter.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was +35.6% over the past 5 years. Earnings growth for 2021 is a modest +90.2%.
Asensus Surgical Inc. (NYSE:ASXC)’s Major holders
Insiders own 1.79% of the company shares, while shares held by institutions stand at 10.06% with a share float percentage of 10.24%. Investors are also buoyed by the number of investors in a company, with Asensus Surgical Inc. having a total of 91 institutions that hold shares in the company. The top two institutional holders are Vanguard Group Inc. (The) with over 2.16 Million shares worth more than $1.35 Million. As of December 30, 2020, Vanguard Group Inc. (The) held 0.93% of shares outstanding.
The other major institutional holder is Renaissance Technologies, LLC, with the holding of over 1.43 Million shares as of December 30, 2020. The firm’s total holdings are worth over $891.88 Thousand and represent 0.61% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are Invesco ETF Tr-Invesco DWA Healthcare Momentum ETF and Vanguard Total Stock Market Index Fund. As of March 30, 2021, the former fund manager holds about 3.05% shares in the company for having 7109464 shares of worth $23.11 Million while later fund manager owns 1.5 Million shares of worth $935Thousand as of December 30, 2020, which makes it owner of about 0.64% of company’s outstanding stock.